Report Ocean, a leading strategic consulting, and Market research firm, in its recent study, estimated Global Amayotrophic Lateral Sclerosis (ALS) Market size by value at USD 902 million in 2023.
Scientists have identified a relationship between ancient viral DNA and susceptibility to neurodegenerative diseases like ...
Benzinga on MSN1d
NeuroSense Moves Toward Early Commercialization Of ALS Treatment In Canada, Eyeing $100M+ MarketNeuroSense Therapeutics Ltd., a late-clinical stage biotechnology company developing novel treatments for severe ...
The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...
ARLINGTON, Virginia—Ben Baldanza, former president and CEO of U.S. ULCC Spirit Airlines, died Nov. 5 after a long battle with ...
Ben Baldanza, who worked four decades in the US airline industry and helped create the ultra-low-cost model as former chief ...
ATH-1105 – A next-generation, novel, orally administered, small molecule drug candidate in development for the potential treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative ...
Leal Therapeutics raised $45 million for drug development, including advancing a promising therapy into clinical trials for ...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder in which neurons in the central nervous system that help ...
“The dedication of our members and the greater community to support Augie’s Quest and ALS research and care has been incredibly moving,” said Chris Smith, President and CEO of Fitness World. “By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback